ASTRIA THERAPEUTICS INC's ticker is and the CUSIP is 04635X102. A total of 33 filers reported holding ASTRIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,483,000 | +201.3% | 274,719 | 0.0% | 0.03% | +222.2% |
Q2 2022 | $824,000 | -55.3% | 274,719 | 0.0% | 0.01% | -55.0% |
Q1 2022 | $1,843,000 | +24.4% | 274,719 | 0.0% | 0.02% | +17.6% |
Q4 2021 | $1,481,000 | -25.5% | 274,719 | +22.3% | 0.02% | -32.0% |
Q3 2021 | $1,987,000 | – | 224,719 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Altium Capital Management LP | 1,347,088 | $10,049,276 | 5.24% |
Saturn V Capital Management LP | 1,219,093 | $9,094,434 | 3.81% |
Affinity Asset Advisors, LLC | 1,000,300 | $7,462,238 | 2.10% |
Fairmount Funds Management LLC | 1,901,397 | $14,184,422 | 1.71% |
Tri Locum Partners LP | 598,128 | $4,462,035 | 1.43% |
Vivo Capital, LLC | 1,681,199 | $12,541,745 | 1.37% |
SPHERA FUNDS MANAGEMENT LTD. | 580,599 | $4,331,269 | 0.79% |
Ghost Tree Capital, LLC | 300,000 | $2,238,000 | 0.74% |
DAFNA Capital Management LLC | 295,493 | $2,204,378 | 0.69% |
Perceptive Advisors | 2,189,462 | $16,333,387 | 0.54% |